10-7566372-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_030569.7(ITIH5):c.2185G>A(p.Ala729Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000194 in 1,600,316 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000018 ( 0 hom. )
Consequence
ITIH5
NM_030569.7 missense
NM_030569.7 missense
Scores
7
8
Clinical Significance
Conservation
PhyloP100: 4.56
Genes affected
ITIH5 (HGNC:21449): (inter-alpha-trypsin inhibitor heavy chain 5) This gene encodes a heavy chain component of one of the inter-alpha-trypsin inhibitor (ITI) family members. ITI proteins are involved in extracellular matrix stabilization and in the prevention of tumor metastasis. They are also structurally related plasma serine protease inhibitors and are composed of a light chain and varying numbers of heavy chains. This family member is thought to function as a tumor suppressor in breast and thyroid cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
?
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ITIH5 | NM_030569.7 | c.2185G>A | p.Ala729Thr | missense_variant | 13/14 | ENST00000397146.7 | |
ITIH5 | NM_032817.6 | c.1543G>A | p.Ala515Thr | missense_variant | 9/10 | ||
ITIH5 | XM_011519713.4 | c.2260G>A | p.Ala754Thr | missense_variant | 14/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ITIH5 | ENST00000397146.7 | c.2185G>A | p.Ala729Thr | missense_variant | 13/14 | 1 | NM_030569.7 | P1 | |
ITIH5 | ENST00000613909.4 | c.1543G>A | p.Ala515Thr | missense_variant | 9/10 | 1 | |||
ITIH5 | ENST00000473591.1 | n.447G>A | non_coding_transcript_exon_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes ? AF: 0.0000329 AC: 5AN: 151864Hom.: 0 Cov.: 30
GnomAD3 genomes
?
AF:
AC:
5
AN:
151864
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250054Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135066
GnomAD3 exomes
AF:
AC:
6
AN:
250054
Hom.:
AF XY:
AC XY:
6
AN XY:
135066
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000180 AC: 26AN: 1448452Hom.: 0 Cov.: 31 AF XY: 0.0000195 AC XY: 14AN XY: 717974
GnomAD4 exome
AF:
AC:
26
AN:
1448452
Hom.:
Cov.:
31
AF XY:
AC XY:
14
AN XY:
717974
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000329 AC: 5AN: 151864Hom.: 0 Cov.: 30 AF XY: 0.0000270 AC XY: 2AN XY: 74178
GnomAD4 genome
?
AF:
AC:
5
AN:
151864
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
74178
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
?
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 23, 2023 | The c.2185G>A (p.A729T) alteration is located in exon 13 (coding exon 13) of the ITIH5 gene. This alteration results from a G to A substitution at nucleotide position 2185, causing the alanine (A) at amino acid position 729 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
Sift4G
Benign
T;T
Vest4
MutPred
Gain of phosphorylation at A729 (P = 0.0241);.;
MVP
ClinPred
D
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at